osimertinib
astrazeneca
['adaura', 'aura ,(-laura)']
if anyone had doubts: #asco23 impressive results from adaura - os hazard ratio [hr] of 0.49; 95.03% confidence interval [ci] 0.33-0.73; p=0.0004), and in the overall trial population (stages ib-iiia) (18% data maturity, os hr of 0.49; 95.03% ci 0.34-0.70; p&lt;0.0001). looking 
Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition